Jade Biosciences

JBIO

Biotechnology · Healthcare

Exchange

NASDAQ

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Track this stock — start free trial

Winston Score History

The full picture

Jade Biosciences is a clinical-stage biotechnology company focused on developing treatments for autoimmune diseases — conditions where the body's immune system mistakenly attacks healthy tissue. The company is working on experimental drugs that target the underlying causes of these diseases rather than just managing symptoms. Its potential customers are patients and healthcare providers dealing with conditions like lupus and other serious immune disorders.

Jade Biosciences does not yet sell any approved products, so it currently earns no revenue. The company funds its research through investor capital, which explains its negative returns and zero margins. It operates primarily in the United States and competes in a crowded autoimmune drug development space alongside much larger pharmaceutical companies. The biggest risk the company faces is clinical failure — if its experimental drugs do not prove safe and effective in trials, the company could run out of funding before reaching the market.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

+32.7% YoY

YoY Growth Rate

Strong earnings growth

Insider Activity

14.4%ownership

↓ Declining

Insider ownership declining — could be dilution or selling

Cash Runway

~3 years

$461M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

$461M cash & investments at current burn rate

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

N/A

—

Data not available

Profit after running costs

Operating Margin

N/A

—

Data not available

Return on the money invested

ROCE

-37.4%

Weak — -37.4% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

—

Data not available

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

8/8 quarters

Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

—

Data not available

Spare cash per sale

FCF Margin

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial